000 | 01948 a2200541 4500 | ||
---|---|---|---|
005 | 20250515050441.0 | ||
264 | 0 | _c20070119 | |
008 | 200701s 0 0 eng d | ||
022 | _a0090-3493 | ||
024 | 7 |
_a10.1097/01.CCM.0000251123.70632.4E _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStocker, Christian F | |
245 | 0 | 0 |
_aMechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. _h[electronic resource] |
260 |
_bCritical care medicine _cJan 2007 |
||
300 |
_a252-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 |
_aCardiac Output, Low _xdrug therapy |
650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 |
_aDiastole _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrazones _xpharmacology |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMilrinone _xpharmacology |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 |
_aPulmonary Gas Exchange _xdrug effects |
650 | 0 | 4 |
_aPyridazines _xpharmacology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSimendan |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
700 | 1 | _aShekerdemian, Lara S | |
700 | 1 | _aNørgaard, Martin A | |
700 | 1 | _aBrizard, Christan P | |
700 | 1 | _aMynard, Jonathan P | |
700 | 1 | _aHorton, Steven B | |
700 | 1 | _aPenny, Daniel J | |
773 | 0 |
_tCritical care medicine _gvol. 35 _gno. 1 _gp. 252-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.CCM.0000251123.70632.4E _zAvailable from publisher's website |
999 |
_c16703713 _d16703713 |